Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Trials|May 20, 2020
The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in VietnamLeanne McCabe, Ian R White, Nguyen Van Vinh Chau, et al.
F1000Research|December 3, 2020
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settingsNurulamin M Noor, Sarah L Pett, Hanif Esmail, et al.
Clinical and Vaccine Immunology : CVI|October 20, 2006
Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samplesWayne B Dyer, Sarah L Pett, John S Sullivan, et al.
Antiviral Therapy|March 27, 2009
A phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patientsSarah L Pett, Michael C McCarthy, David A Cooper, et al.
Plos One|March 5, 2013
Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control studySonja M Bjerk, Jason V Baker, Sean Emery, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2012
A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adultsDianne Carey, Sarah L Pett, Mark Bloch, et al.
AIDS (London, England)|April 30, 2021
Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United KingdomRachel Hung, Nisha Patel, Julie Fox, et al.
Plos One|October 17, 2013
Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiencyDenise C Hsu, Stephen J Kerr, Thatri Iampornsin, et al.
The Journal of Infection|December 12, 2013
Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapyDenise C Hsu, Stephen J Kerr, Parawee Thongpaeng, et al.
AIDS (London, England)|October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIVJames E Burns, Oliver T Stirrup, David Dunn, et al.
Pageof 6